Poldine metilsulfate is a synthetic anticholinergic agent classified as an antimuscarinic, primarily utilized for the management of Parkinson's disease by blocking muscarinic acetylcholine receptors. As… Read more
Poldine metilsulfate is a synthetic anticholinergic agent classified as an antimuscarinic, primarily utilized for the management of Parkinson's disease by blocking muscarinic acetylcholine receptors. As a therapeutic alternative for patients experiencing complications from other treatments, its production requires rigorous analytical oversight. This category provides access to essential Poldine metilsulfate reference standards, including the active pharmaceutical ingredient, relevant pharmacopeial and non-pharmacopeial impurities, and stable isotope labelled compounds. Pharmaceutical laboratories rely on these high-quality materials for precise impurity profiling, method validation, and ongoing quality control. By utilizing these characterized reference materials, researchers and analysts can ensure accurate identification and quantification of the parent drug and its related substances throughout the drug development lifecycle, supporting compliance with regulatory standards for safety and efficacy in pharmaceutical manufacturing.